Comparative effectiveness of endovacular interventions for lower extremity arterial disease
Endovascular interventions for acute and chronic aortic conditions
Dr. Vartanian graduated from Stanford University with a Bachelors degree in Biology and then went on to Saint Louis University for his medical education. He finished his general surgery residency at the University of California, San Francisco (UCSF) in 2010. During his residency, he spent two years working in the Laboratory for Accelerated Vascular Research (LAVR) under the direction of Rong Wang, Ph.D. His research focused on notch signaling and how that plays a critical role in vascular morphology during embryonic vascular development. Dr. Vartanian completed the fellowship in Vascular and Endovascular Surgery and is now on faculty at UCSF.
Dr. Vartanian is interested in comparing the effectiveness of endovascular treatments for peripheral arterial disease. By understanding the safety, effectiveness, and cost of each intervention, the aim of the research is to assist patients and clinicians in making informed decisions about treatment options.
Causey MW, Ahmed A, Wu B, Gasper WJ, Reyzelman A, Vartanian SM, Hiramoto JS, Conte MS. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg. 2016 Jun; 63(6):1563-1573.e2. View in PubMed
Fernandez CC, Sobel JD, Gasper WJ, Vartanian SM, Reilly LM, Chuter TA, Hiramoto JS. Standard off-the-shelf versus custom-made multibranched thoracoabdominal aortic stent grafts. J Vasc Surg. 2016 May; 63(5):1208-15. View in PubMed
Han SM, Wu B, Eichler CM, Reilly LM, Vartanian SM, Conte MS, Hiramoto J. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease. Vasc Endovascular Surg. 2015 Apr; 49(3-4):69-74. View in PubMed
Vartanian SM, Conte MS. Surgical intervention for peripheral arterial disease. Circ Res. 2015 Apr 24; 116(9):1614-28. View in PubMed
Vartanian SM, Robinson KD, Ofili K, Eichler CM, Hiramoto JS, Reyzelman AM, Conte MS. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service. Ann Vasc Surg. 2015 Apr; 29(3):534-42. View in PubMed
Sobel JD, Vartanian SM, Gasper WJ, Hiramoto JS, Chuter TA, Reilly LM. Lower extremity weakness after endovascular aneurysm repair with multibranched thoracoabdominal stent grafts. J Vasc Surg. 2015 Mar; 61(3):623-9. View in PubMed
Vartanian SM, Johnston PC, Walker JP, Runge SJ, Eichler CM, Reilly LM, Hiramoto JS, Conte MS. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. J Vasc Surg. 2013 Dec; 58(6):1525-31. View in PubMed
Johnston PC, Vartanian SM, Runge SJ, Hiramoto JS, Eichler CM, Owens CD, Schneider DB, Conte MS. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease. J Vasc Surg. 2012 Oct; 56(4):998-1006, 1007.e1; discussion 1006-7. View in PubMed
Murphy PA, Lam MT, Wu X, Kim TN, Vartanian SM, Bollen AW, Carlson TR, Wang RA. Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice. Proc Natl Acad Sci U S A. 2008 Aug 5; 105(31):10901-6. View in PubMed
Vartanian SM, Sarkar R. Therapeutic angiogenesis. Vasc Endovascular Surg. 2007 Jun-Jul; 41(3):173-85. View in PubMed
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.